(SUNS) Sunrise Realty Trust - Overview
Stock: CRE Loans, Mezzanine Loans, B-Notes, CMBS, Preferred Equity
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 11.61% |
| Yield on Cost 5y | 12.75% |
| Yield CAGR 5y | 90.48% |
| Payout Consistency | 100.0% |
| Payout Ratio | 146.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 40.0% |
| Relative Tail Risk | -9.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.27 |
| Alpha | -26.12 |
| Character TTM | |
|---|---|
| Beta | 0.881 |
| Beta Downside | 1.102 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.27% |
| CAGR/Max DD | -0.02 |
Description: SUNS Sunrise Realty Trust January 25, 2026
Sunrise Realty Trust, Inc. (NASDAQ:SUNS) is a newly-established (2023) commercial-real-estate (CRE) lender headquartered in West Palm Palm, Florida. Its core business is originating CRE loans secured by property assets and providing capital to borrowers and sponsors.
The firm is actively diversifying its balance sheet beyond senior loans, targeting a mix of mortgage loans, mezzanine financing, B-notes, CMBS, and debt-like preferred equity across office, industrial, multifamily, and retail asset classes.
Key recent metrics suggest a challenging yet opportunistic environment for CRE lending: U.S. CRE loan originations fell 4.2% YoY in Q4 2025 to $22.3 bn (S&P Global), while industrial vacancy rates hit a historic low of 4.1% (CBRE) and office vacancy rose to 19.3% (JLL), indicating sector-specific risk-reward dynamics.
Macro-level drivers remain dominated by the Federal Reserve’s policy stance; the policy rate has been steady at 5.25%-5.50% since mid-2024, keeping borrowing costs elevated and pressuring loan spreads, but also supporting higher yields on CMBS and preferred equity securities.
Assuming Sunrise can maintain underwriting discipline and leverage its diversified product suite, its exposure to the low-vacancy industrial segment could offset higher risk in office-focused loans, though any further rate hikes would compress net interest margins.
For a data-driven deep-dive into SUNS’s valuation assumptions and scenario analysis, consider exploring the platform on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 12.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -2.74 > 1.0 |
| NWC/Revenue: 862.4% < 20% (prev 218.8%; Δ 643.6% < -1%) |
| CFO/TA -0.01 > 3% & CFO -2.94m > Net Income 12.4m |
| Net Debt (61.6m) to EBITDA (13.8m): 4.46 < 3 |
| Current Ratio: 3.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (13.3m) vs 12m ago 94.61% < -2% |
| Gross Margin: 76.58% > 18% (prev 0.94%; Δ 7564 % > 0.5%) |
| Asset Turnover: 10.03% > 50% (prev 4.28%; Δ 5.75% > 0%) |
| Interest Coverage Ratio: 4.33 > 6 (EBITDA TTM 13.8m / Interest Expense TTM 2.86m) |
Altman Z'' 5.00
| A: 0.71 (Total Current Assets 258.8m - Total Current Liabilities 74.2m) / Total Assets 258.8m |
| B: -0.01 (Retained Earnings -2.52m / Total Assets 258.8m) |
| C: 0.06 (EBIT TTM 12.4m / Avg Total Assets 213.3m) |
| D: -0.03 (Book Value of Equity -2.39m / Total Liabilities 74.2m) |
| Altman-Z'' Score: 5.00 = AAA |
What is the price of SUNS shares?
Over the past week, the price has changed by -1.06%, over one month by -3.23%, over three months by +4.17% and over the past year by -11.84%.
Is SUNS a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SUNS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12.1 | 30.4% |
| Analysts Target Price | 12.1 | 30.4% |
| ValueRay Target Price | 11.5 | 23.4% |
SUNS Fundamental Data Overview February 03, 2026
P/E Forward = 7.0175
P/S = 6.5081
P/B = 0.6837
P/EG = 0.6381
Revenue TTM = 21.4m USD
EBIT TTM = 12.4m USD
EBITDA TTM = 13.8m USD
Long Term Debt = unknown (0.0)
Short Term Debt = 67.2m USD (from shortTermDebt, last quarter)
Debt = 67.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 61.6m USD (from netDebt column, last quarter)
Enterprise Value = 187.8m USD (126.2m + Debt 67.2m - CCE 5.55m)
Interest Coverage Ratio = 4.33 (Ebit TTM 12.4m / Interest Expense TTM 2.86m)
EV/FCF = -63.90x (Enterprise Value 187.8m / FCF TTM -2.94m)
FCF Yield = -1.56% (FCF TTM -2.94m / Enterprise Value 187.8m)
FCF Margin = -13.73% (FCF TTM -2.94m / Revenue TTM 21.4m)
Net Margin = 57.77% (Net Income TTM 12.4m / Revenue TTM 21.4m)
Gross Margin = 76.58% ((Revenue TTM 21.4m - Cost of Revenue TTM 5.01m) / Revenue TTM)
Gross Margin QoQ = 59.83% (prev 73.75%)
Tobins Q-Ratio = 0.73 (Enterprise Value 187.8m / Total Assets 258.8m)
Interest Expense / Debt = 2.14% (Interest Expense 1.44m / Debt 67.2m)
Taxrate = 0.0% (0.0 / 4.05m)
NOPAT = 12.4m (EBIT 12.4m * (1 - 0.00%))
Current Ratio = 3.49 (Total Current Assets 258.8m / Total Current Liabilities 74.2m)
Debt / Equity = 0.36 (Debt 67.2m / totalStockholderEquity, last quarter 184.6m)
Debt / EBITDA = 4.46 (Net Debt 61.6m / EBITDA 13.8m)
Debt / FCF = -20.96 (negative FCF - burning cash) (Net Debt 61.6m / FCF TTM -2.94m)
Total Stockholder Equity = 167.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.80% (Net Income 12.4m / Total Assets 258.8m)
RoE = 7.41% (Net Income TTM 12.4m / Total Stockholder Equity 167.0m)
RoCE = 7.41% (EBIT 12.4m / Capital Employed (Equity 167.0m + L.T.Debt 0.0))
RoIC = 4.75% (NOPAT 12.4m / Invested Capital 260.5m)
WACC = 6.72% (E(126.2m)/V(193.3m) * Re(9.16%) + D(67.2m)/V(193.3m) * Rd(2.14%) * (1-Tc(0.0)))
Discount Rate = 9.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 38.86%
Fair Price DCF = unknown (Cash Flow -2.94m)
EPS Correlation: -25.11 | EPS CAGR: -62.34% | SUE: 0.0 | # QB: 0
Revenue Correlation: 41.93 | Revenue CAGR: 33.22% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.30 | Chg30d=-0.007 | Revisions Net=+2 | Analysts=3
EPS next Year (2026-12-31): EPS=1.28 | Chg30d=+0.003 | Revisions Net=+0 | Growth EPS=+8.3% | Growth Revenue=+42.6%